AusBiotech and Oktopi enter into new Australian ecosystem partnership
14 June 2026
AusBiotech and Oktopi have entered into a new Australian ecosystem partnership designed to provide meaningful benefit to AusBiotech members through discounted access to the Oktopi platform.
Under the agreement, Oktopi will become an AusBiotech Business Solutions Program Partner, expanding the range of specialised solutions and benefits available to members across Australia's life sciences sector.
The AusBiotech Business Solutions Program connects all members with a growing range of service providers offering exclusive discounts, preferential pricing, and tailored solutions designed specifically for biotechnology, medical technology, and health tech organisations.
The Oktopi platform is an AI-informed ecosystem connecting knowledge, workflows, and community to collaborate on medicine development. Through this partnership, AusBiotech members will receive preferential pricing.
AusBiotech CEO, Rebekah Cassidy, said the partnership reflects AusBiotech's ongoing commitment to helping members access tools, expertise, and services that may assist in an increasingly competitive global environment.
"Australia's life sciences sector is built on world-class research, entrepreneurship, innovation, and expertise. Opening doors to help organisations access new tools, knowledge, and capabilities that may accelerate development and commercialisation is critical to maintaining our forward momentum.
"The AusBiotech Business Solutions Program is designed to connect members with providers that seek to service the unique needs of our sector. We are pleased to welcome Oktopi to our growing Program and look forward to supporting our members with access to even more innovative solutions, while delivering meaningful cost savings.”
Comments from Oktopi Co-Founder and CEO, Dr Craig Rayner:
"We are proud to partner with AusBiotech, who are on the front foot in recognising that AI, used responsibly and built on the right infrastructure, can accelerate the whole Australian biotech ecosystem.
“That is what Oktopi is built for: AI-native infrastructure that amplifies expert teams rather than replacing them, so they make sharper decisions and take more medicines closer to patients."
ENDS
Media inquiries:
Rose Petrass, AusBiotech Communications Advisor / +61 0457 867 780 / [email protected]
Michelle Rayner, Oktopi COO / +61 401 009 749 / [email protected]
About Oktopi
Oktopi is the world's first cognitive infrastructure for medicine development, codifying the expertise behind the best development decisions into a single platform and defining a new operating model for the industry. The platform combines OktoWai™, an AI-informed knowledge engine spanning the full development lifecycle; OktoPilot™, an agentic AI peer reviewer validated against senior experts in a blinded calibration study; OktoLearning, accredited capability development delivered in the flow of work; and The Consortium, a global community, marketplace, and co-development network. Together, they enable teams across the ecosystem, from lean biotechs and global health programmes to investors and pharma, to make higher-quality decisions with greater speed, consistency, and confidence. www.oktopi.com
About AusBiotech
AusBiotech is Australia's leading national and global advocate for life sciences, working to help its more than 3500 members thrive by shaping policy, creating connections, and fostering knowledge sharing. With an unrivalled national convening power, AusBiotech supports its members’ growth by building an Australian life sciences ecosystem that leads in development and commercialisation, creating high-quality, innovative life sciences companies.
ENDS